Carregando...
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
Treatment of Myasthenia Gravis (MG) is still based on non-specific immunosuppression. Long-term high dose corticosteroids is still a major cause of side effects, in young as well as in elderly patients in whom comorbidities further increase the burden of chronic immunosuppression. Moreover, awarenes...
Na minha lista:
Principais autores: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Frontiers Media S.A.
2020-09-01
|
coleção: | Frontiers in Neurology |
Assuntos: | |
Acesso em linha: | https://www.frontiersin.org/article/10.3389/fneur.2020.00981/full |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|